Company intelligence / Profile preview

Genect

Sesto San Giovanni, Italy

Ownership: Private
Development stage: Other

Overview

Genect is an Italian precision medicine and molecular diagnostics company specializing in the distribution and application of advanced diagnostic platforms, particularly the INIFINITI® Plus automation system for pharmacogenetic, oncology, infectious disease, and genetic disorder screening and monitoring. The company partners with diagnostic technology leaders to deliver these solutions to laboratories in Italy and beyond, supporting the adoption of precision medicine in clinical practice.

Therapeutic areas: OncologyInfectious DiseasesRare Diseases
Modalities: Molecular Diagnostics
Industry: Molecular Diagnostics

Partnerships

AutoGenomics

Beyond the preview

Go deeper on Genect.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genect.

Explore the full profile